Status:

ENROLLING_BY_INVITATION

Data Collection, Clinical Care and Interventions in CCR, NCI

Lead Sponsor:

National Cancer Institute (NCI)

Conditions:

Neoplasms

Cancer

Eligibility:

All Genders

4-120 years

Brief Summary

This study provides cancer care through the National Cancer Institute's Medical Oncology Branch (MOB) to patients who are not enrolled in an active treatment research protocol. Patients receive standa...

Detailed Description

Background: * Clinical Investigators within the Center for Cancer Research (CCR) at the National Cancer Institute (NCI) evaluate and treat patients with cancer, HIV, and individuals at risk for devel...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Individuals must be age 2 years or older if therapeutic interventions are required. Otherwise, there are no age restrictions beyond the neonatal period (4 weeks).
  • Individuals will be eligible if they meet one of the following criteria:
  • are seeking a consultation from NCI/CCR.
  • whose medical welfare will be seriously compromised by referral back to the community, such as rare/complex diseases in which community treatment is inadequate or adequate community resources are unavailable.
  • have cancer, HIV, or are at risk for cancer and/or HIV for whom cancer evaluation, treatment or management at the NCI is requested.
  • who will serve or have served as cellular therapy donors, for the treatment of a recipient of cellular therapy on an NCI trial.
  • are participants or biologic family members of deceased participants, where genetic testing is required or a clinically actionable germline pathogenic or likely pathogenic variant with medical implications was discovered by a research laboratory that requires CLIA confirmation. Note: In some cases, enrollment onto this study is also necessary when the prior study on which the involved participant was originally enrolled is closed and/or the participant is now off study.
  • The individual or their Legally Authorized Representative is able and willing to provide informed consent.
  • EXCLUSION CRITERIA:
  • None

Exclusion

    Key Trial Info

    Start Date :

    June 10 2004

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    10000 Patients enrolled

    Trial Details

    Trial ID

    NCT00923065

    Start Date

    June 10 2004

    Last Update

    January 7 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892